Preventing Substance Use Among Indigenous Adolescents in the USA, Canada, Australia and New Zealand: a Systematic Review of the Literature

被引:28
|
作者
Snijder, Mieke [1 ]
Stapinski, Lexine [1 ]
Lees, Briana [1 ]
Ward, James [2 ]
Conrod, Patricia [3 ]
Mushquash, Christopher [4 ]
Belone, Lorenda [5 ]
Champion, Katrina [1 ]
Chapman, Cath [1 ]
Teesson, Maree [1 ]
Newton, Nicola [1 ]
机构
[1] Univ Sydney, Fac Hlth & Med, Matilda Ctr, Sydney, NSW 2006, Australia
[2] Flinders Univ S Australia, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia
[3] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada
[4] Lakehead Univ, Northern Ontario Sch Med, Ctr Rural & Northern Hlth Res, Thunder Bay, ON, Canada
[5] Univ New Mexico, Coll Educ, Dept Hlth Exercise & Sports Sci, Albuquerque, NM 87131 USA
关键词
Substance use; Prevention; Indigenous; Native; Aboriginal; Adolescent; Evaluation; ALCOHOL-USE; DRUG-USE; USE DISORDERS; AMERICAN; COMMUNITY; SCHOOL; ABUSE; INTERVENTIONS; PROGRAM; YOUTH;
D O I
10.1007/s11121-019-01038-w
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This systematic review assessed the current evidence base of substance use prevention programs for Indigenous adolescents in the USA, Canada, Australia and New Zealand. The authors investigated (a) the outcomes, type, setting and context of prevention programs; (b) the common components of beneficial prevention programs; and (c) the methodological quality of evaluations of included prevention programs. The authors searched eight peer-reviewed and 20 grey literature databases for studies published between 1 January 1990 and 31 August 2017. Data extracted included type of program (culturally adapted, culture-based or unadapted), the setting (school, community, family or multi-setting), delivery (computerised or traditional), context (Indigenous-specific or multi-cultural environment) and common components of the programs. Program evaluation methodologies were critically appraised against standardised criteria. This review identified 26 eligible studies. Substance use prevention programs for Indigenous youth led to reductions in substance use frequency and intention to use; improvements in substance-related knowledge, attitudes and resistance strategies; and delay in substance use initiation. Key elements of beneficial programs included substance use education, skills development, cultural knowledge enhancement and community involvement in program development. Five programs were rated as methodologically strong, seven were moderate and fourteen were weak. Prevention programs have the potential to reduce substance use among Indigenous adolescents, especially when they are developed in partnership with Indigenous people. However, more rigorously conducted evaluation trials are required to strengthen the evidence base.
引用
收藏
页码:65 / 85
页数:21
相关论文
共 50 条
  • [1] Preventing Substance Use Among Indigenous Adolescents in the USA, Canada, Australia and New Zealand: a Systematic Review of the Literature
    Mieke Snijder
    Lexine Stapinski
    Briana Lees
    James Ward
    Patricia Conrod
    Christopher Mushquash
    Lorenda Belone
    Katrina Champion
    Cath Chapman
    Maree Teesson
    Nicola Newton
    Prevention Science, 2020, 21 : 65 - 85
  • [2] Substance Use Prevention Programs for Indigenous Adolescents in the United States of America, Canada, Australia and New Zealand: Protocol for a Systematic Review
    Snijder, Mieke
    Stapinski, Lexine
    Lees, Briana
    Newton, Nicola
    Champion, Katrina
    Chapman, Catherine
    Ward, James
    Teesson, Maree
    JMIR RESEARCH PROTOCOLS, 2018, 7 (02):
  • [3] Epilepsy in the Indigenous peoples in Canada, Australia, New Zealand, and the USA: a systematic scoping review
    Keenan, Ngaire F.
    Aitchison, Sean G.
    Jette, Nathalie
    Parko, Karen L.
    Roach, Pamela
    Dos Santos, Angela
    Archer, John
    Andersen, Erik
    Stairmand, Jeannine L.
    Stanley, James
    Sadleir, Lynette G.
    LANCET GLOBAL HEALTH, 2025, 13 (04):
  • [4] Systematic review of interventions for Indigenous adults with mental and substance use disorders in Australia, Canada, New Zealand and the United States
    Leske, Stuart
    Harris, Meredith G.
    Charlson, Fiona J.
    Ferrari, Alize J.
    Baxter, Amanda J.
    Logan, Jacquie M.
    Toombs, Maree
    Whiteford, Harvey
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 (11): : 1040 - 1054
  • [5] Systematic review of rheumatic disease phenotypes and outcomes in the Indigenous populations of Canada, the USA, Australia and New Zealand
    Hurd, Kelle
    Barnabe, Cheryl
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (04) : 503 - 521
  • [6] Systematic review of rheumatic disease phenotypes and outcomes in the Indigenous populations of Canada, the USA, Australia and New Zealand
    Kelle Hurd
    Cheryl Barnabe
    Rheumatology International, 2017, 37 : 503 - 521
  • [7] Prevalence of diabetes in pregnancy among Indigenous women in Australia, Canada, New Zealand, and the USA: a systematic review and meta-analysis
    Voaklander, Britt
    Rowe, Stewart
    Sanni, Omolara
    Campbell, Sandra
    Eurich, Dean
    Ospina, Maria B.
    LANCET GLOBAL HEALTH, 2020, 8 (05): : E681 - E698
  • [8] A systematic review of ageing in place among Indigenous People in Canada, USA, Mexico, Chile and New Zealand
    Gallardo-Peralta, Lorena P.
    Rodriguez-Rodriguez, Vicente
    Valencia Galvez, Lorena
    Tereucan Angulo, Julio
    Soto Higuera, Abel
    Sanchez-Moreno, Esteban
    HEALTH PSYCHOLOGY AND BEHAVIORAL MEDICINE, 2023, 11 (01):
  • [9] A review of community engagement in cancer control studies among Indigenous people of Australia, New Zealand, Canada and the USA
    Miller, J.
    Knott, V. E.
    Wilson, C.
    Roder, D.
    EUROPEAN JOURNAL OF CANCER CARE, 2012, 21 (03) : 283 - 295
  • [10] Traditional and Complementary Medicine Use Among Indigenous Cancer Patients in Australia, Canada, New Zealand, and the United States: A Systematic Review
    Gall, Alana
    Leske, Stuart
    Adams, Jon
    Matthews, Veronica
    Anderson, Kate
    Lawler, Sheleigh
    Garvey, Gail
    INTEGRATIVE CANCER THERAPIES, 2018, 17 (03) : 568 - 581